.png)

Sponsors should limit key-person clauses to the principals whose loss would materially impair execution of the business plan, using objective triggers and a defined cure process. The agreement should preserve operational continuity, require timely LP responses to replacement candidates, and keep an uncured key-person event separate from automatic GP removal.
Key-person provisions define which individuals a family office LP considers essential to a joint venture's success, what events trigger a governance response, and what obligations the sponsor carries until a replacement is approved. In a $15M+ development JV, these provisions must be negotiated and documented before closing. A vague or one-sided key-person clause gives the LP a mechanism to suspend capital contributions, block major decisions, or initiate removal proceedings at the moment the sponsor is most vulnerable. Getting the designation, trigger, and cure language right in the JV agreement or LPA is a structural priority that must be resolved before closing.
Sponsors who have worked through how family offices evaluate key person risk in a first-time fund already understand the diligence lens. This article focuses on the drafting mechanics: which individuals should be named, which triggers to accept, how to cap continuity obligations, and what replacement mechanics protect the sponsor's operational authority during a cure period.
A key person, in the family office LP's framing, is the individual whose judgment, relationships, and execution capacity the LP relied on when committing capital. The designation is personal, not positional. A title like "Managing Partner" or "CEO" carries no automatic key-person status. The LP designates the people who actually sourced the deal, control the construction relationship, manage the lender, and handle LP communication.
In a development JV, family offices typically push to name a short, defined list of individuals. The most common designees are:
The LP's goal is to ensure the people they underwrote are the people running the deal. That is a reasonable position. The sponsor's goal is to make sure the named list does not expand to include every senior team member, which would make routine personnel changes a governance event.
Negotiating the designation list is one of the highest-leverage moments in the JV drafting process. Accepting the wrong individuals as key persons creates governance exposure for the life of the hold.
Drafting principle: The key-person definition should name the individuals whose loss would materially impair the sponsor's ability to execute the business plan, and only those individuals.
The sponsor should propose the initial list, not accept the LP's first draft. Family offices often start with a broader designation than they actually need. A reasoned counter-proposal with role-specific justification is standard practice and rarely a deal-stopper.
The trigger definition determines when the LP's key-person rights activate. Broad trigger language gives the LP a governance lever it can pull in circumstances the sponsor did not anticipate. Narrow trigger language limits the clause to genuine continuity events.
Key point: Sponsors should insist that every trigger in the key-person clause has a defined, objective standard. Subjective language is a governance risk that compounds over a multi-year hold.
Understanding how these trigger mechanics interact with the broader LP structure is part of what separates a well-negotiated JV from one that creates control problems mid-project. Sponsors choosing between deal-by-deal and blind pool structures will find that the governance expectations differ meaningfully between the two, and key-person trigger scope is one of the clearest examples of that difference.
After a key-person event is triggered, the JV agreement typically imposes continuity obligations on the sponsor. These obligations define what the GP must do to keep the project running while a cure or replacement process unfolds. Sponsors often accept these provisions without reading them carefully, which creates problems when an event actually occurs.
These are reasonable. They protect the LP from the sponsor using the transition period to restructure the deal in ways the LP cannot monitor.
The risk is when continuity language expands into operational control. Watch for provisions that:
A suspended capital contribution during an active construction draw period can trigger a default with the senior lender. Sponsors should negotiate a carve-out requiring the LP to fund draws necessary to avoid a lender default, even if a key-person event is pending resolution.
The continuity obligation should preserve the status quo. It should not transfer operational decision-making to the LP during the cure window.
The cure period is the window the sponsor has to resolve a key-person event before the LP's remedial rights escalate. Standard practice in institutional JV agreements gives the sponsor a defined window, typically measured in weeks rather than months, to identify and present a replacement candidate. Some agreements allow a single extension if the sponsor demonstrates active progress, provided that extension is also defined in the document.
If the sponsor cannot present an approved replacement within the cure period, the LP's remedial rights typically escalate. Common escalation paths include:
The cure period should be long enough to conduct a real search. A development JV requires a replacement candidate with construction and LP-relationship experience. Sponsors should resist cure windows that do not allow enough time to identify, vet, and present a qualified candidate.
For context on how these replacement mechanics interact with the LP's broader removal rights, the ILPA Principles 3.0 provide a widely referenced framework for how institutional LPs approach key-person events and reinstatement procedures in fund documents.
Key-person provisions and removal rights are separate mechanisms, they share a boundary that sponsors must understand before signing. A key-person event activates a cure and replacement process. The LP's removal rights remain on a separate track. The two clauses carry different standards and different timelines.
A key-person event activates a cure and replacement process for a named individual. The GP entity remains in place. Removal of the GP entity is a separate action, governed by the removal clause, which typically requires a higher standard such as cause, gross negligence, or a supermajority LP vote.
The risk for sponsors is when the JV agreement allows an uncured key-person event to convert into a removal trigger. Language to watch for:
These provisions collapse the two mechanisms into one, effectively giving the LP a removal path through the key-person clause without meeting the higher removal standard. Sponsors should resist any language that treats an uncured key-person event as automatic cause for removal.
An uncured key-person event should escalate LP rights within the JV (decision suspension, distribution acceleration) without automatically triggering removal. If the LP wants to pursue removal after an uncured key-person event, it should be required to satisfy the removal standard independently.
Sponsors raising $5M to $250M in institutional equity should treat the boundary between key-person and removal language as one of the most important governance issues in the operating agreement. Family offices that understand this distinction will often accept a clean separation. Those that push to merge the two mechanisms should be met with a clear counter-proposal and a reasoned explanation of why the separation protects both parties.
For a full treatment of what family offices look for before committing LP equity at this scale, the underwriting framework family offices use before a first LP commitment covers how governance structure factors into the allocation decision.
The key-person clause creates the framework. What happens during the hold determines whether that framework ever gets tested. Sponsors who maintain clean governance records throughout the project reduce the LP's ability to assert a key-person event based on ambiguous facts.
{{main-cta}}
Sponsors who treat governance documentation as a live function, rather than a closing-day exercise, rarely face key-person disputes that escalate to arbitration. The LP's ability to assert a trigger depends heavily on what the record shows.
A well-negotiated key-person framework has five components, all present in the signed document before closing:
Sponsors who present this framework in the initial redline, rather than accepting the LP's first draft, negotiate from a stronger position. Family offices that have structured multiple JVs will recognize the framework as institutional-grade. Those that push back on every element are signaling a governance posture that will surface again during the hold.
IRC Partners works with sponsors raising $5M to $250M in institutional equity to structure JV agreements, LP operating agreements, and governance frameworks that hold up under family office diligence. If you are preparing to negotiate key-person language before signing, speaking with an advisor before the redline goes back is the right sequence.
The list should reflect the people whose loss would materially impair execution of the specific business plan, covering deal authority, construction oversight, and LP communication. Extending the designation beyond those principals creates a staffing covenant that turns routine personnel changes into governance events.
A key-person event triggers a cure and replacement process for a named individual. The GP entity remains in place throughout that process. GP removal is a separate action governed by a higher standard, typically cause, gross negligence, or a supermajority LP vote. Sponsors should ensure the JV agreement keeps these two mechanisms on separate tracks, with no language allowing an uncured key-person event to convert into automatic cause for removal.
Many JV agreements give the LP the right to suspend capital contributions during a cure period. Sponsors should negotiate a carve-out requiring the LP to fund draws necessary to avoid a default with the senior construction lender. A suspended draw during active construction can trigger a lender default regardless of the LP's internal governance dispute.
Sponsors should push for a specific percentage threshold in place of vague language like "substantially all of their time." ILPA Principles 3.0 identifies an 80% time-commitment standard as the appropriate trigger threshold for key-person time-devotion provisions. A defined percentage is objective and measurable. Subjective language gives the LP a trigger whenever a key person takes on additional responsibilities or manages a parallel project, even if project performance is unaffected.
The cure period should run from the date of written LP notice, not from the date the underlying event occurred. Sponsors should resist cure windows that do not allow enough time to identify, vet, and present a replacement candidate with the construction and LP-relationship experience a development project requires. The ILPA Model LPA uses 90 days as the outer threshold before termination rights activate, which provides a useful benchmark when negotiating the window length.
The JV agreement should require the LP's approval to be subject to a reasonableness standard, with a defined response window specified in the document. If the LP does not respond within that window, the agreement should treat silence as approval. Without this provision, the LP can block a replacement through inaction and allow the cure period to expire without a resolution the sponsor caused.
Sponsors should maintain quarterly meeting minutes with named attendance, signed authorization records for major decisions, LP communication logs attributed to the responsible key person, and a project role matrix showing how any time-devotion standard is being met. A single governance file per JV containing the operating agreement, key-person designation, all LP notices, and the cure-period correspondence log is the minimum standard for a hold of three years or longer.
IRC Partners advises operators raising $5M to $250M of institutional capital on structure, positioning, and round architecture. We take seven strategic partners per quarter. No placement agent model. No success-only theater. Capital is raised on the strength of how the deal is built. If you want your current raise reviewed before it reaches the market and silently fails, apply here.
You get one shot to raise the right way. If this raise is worth doing, it’s worth doing with precision, leverage, and control.
This isn’t a practice run. Serious capital. Serious strategy. Let’s raise it right.
We onboard a maximum of seven
new strategic partners each quarter, by application only, to maximize your chances of securing the capital you need.